The present invention pertains to: a drug for preventing and/or treating cognitive dysfunction and/or a neurodegenerative disease accompanied by accumulation of prionoids, said drug comprising hemagglutinating virus of Japan envelope as an active ingredient; and a combined use of the aforesaid drug with an immune checkpoint inhibitor.
NOVEL THERAPEUTIC AGENT FOR PRIONOID DISEASES